Efficacy of Rituximab in Managing Refractory Juvenile Systemic Lupus Erythematosus with Macrophage Activation Syndrome: A Case Report and Literature Review

    Sasmita Mishra, Subhasree Madhual, Maitreyee Panda
    Studysummary This study reports that Rituximab may be a safe and effective treatment for refractory juvenile systemic lupus erythematosus complicated by macrophage activation syndrome, allowing for successful steroid tapering.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →